Pablo Jordan
Keine laufenden Positionen mehr
Profil
Pablo Jordan worked as a Principal at Equifax, Inc. and as a Marketing Manager at Ventana Medical Systems, Inc. He also held positions as Vice President-International Business Development at Biotheranostics, Inc., Vice President-Oncology at bioMérieux SA, and Executive Vice President-Business Development at Definiens AG.
Additionally, he worked as a Manager-Strategic Alliances at Roche Diagnostics France SASU.
Jordan graduated from Universidad Autónoma de Madrid with a graduate degree and also holds a graduate degree from Université Paris II Panthéon Assas.
Ehemalige bekannte Positionen von Pablo Jordan
| Unternehmen | Position | Ende |
|---|---|---|
| EQUIFAX INC. | Corporate Officer/Principal | - |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Vertrieb & Marketing | - |
Roche Diagnostics France SASU
 Roche Diagnostics France SASU Medical SpecialtiesHealth Technology Roche Diagnostics develops test and diagnostic solutions in vitro to serve the patients. The company was founded on February 4, 1991 and is headquartered in Meylan, France. | Corporate Officer/Principal | - |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| BIOMÉRIEUX | Corporate Officer/Principal | - |
Ausbildung von Pablo Jordan
| Université Paris II Panthéon Assas | Graduate Degree |
| Universidad Autónoma de Madrid | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOMÉRIEUX | Health Technology |
| EQUIFAX INC. | Commercial Services |
| Private Unternehmen | 4 |
|---|---|
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Technology Services |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Roche Diagnostics France SASU
Roche Diagnostics France SASU Medical SpecialtiesHealth Technology Roche Diagnostics develops test and diagnostic solutions in vitro to serve the patients. The company was founded on February 4, 1991 and is headquartered in Meylan, France. | Health Technology |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
